MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-GJ-01-0225063
Clementis Formulation Private Limited
Clementis Formulation Private Limited - chemicals and materials in Ahmedabad, Gujarat, India. Directors, charges & compliance details.
Revenue · FY 2025
₹4.1 Cr
▲ 3831802% YoY
Net loss · FY 2025
₹32.15 Lakh
Net margin -7.8%
EBITDA · FY 2025
₹26.55 Lakh
EBITDA margin 6.5%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹9 Cr
Secured borrowings
Company age
5 yrs
Est. 2021
Directors on board
2
As per MCA filings
About Clementis Formulation Private Limited
Data last updated:
Clementis Formulation Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the industrial chemicals segment of the chemicals and materials sector. It was incorporated on 18 February 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24290GJ2021PTC120378.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors Jigneshkumar Shah and Bharat Kishorchandra Shah.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 279 Panchratna Estate Ar – Changodar Ta – Sanand, Ahmedabad, Gujarat, India – 382213.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.1 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹32.15 Lakh (net margin -7.8%) and EBITDA of ₹26.55 Lakh (EBITDA margin 6.5%).
As per MCA filings, the company has open charges of ₹9 Cr on record.
Clementis Formulation Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-GJ-01-0225063). The current compliance status is marked as compliant by the Registrar of Companies.
Company Details of Clementis Formulation Private Limited
CIN U24290GJ2021PTC120378
Registration Number 120378
Incorporation Date 18 February 2021
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-GJ-01-0225063
Recognitions & Rankings of Clementis Formulation
Contact Details
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address279 Panchratna Estate Ar – Changodar Ta – Sanand, Ahmedabad, Gujarat, India – 382213
- IndustryChemicals and Materials, Industrial Chemicals
Comprehensive company report
Clementis Formulation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Clementis Formulation Private Limited
The main business activity of Clementis Formulation is trade. In detail, this covers retail trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Clementis Formulation Private Limited FY 2025 filings available
Clementis Formulation Private Limited reported revenue of ₹4.1 Cr (up 3831802% YoY) for FY 2025.
Revenue · FY 2025
₹4.1 Cr ▲ 3831802%
Net loss · FY 2025
₹32.15 Lakh margin -7.8%
EBITDA · FY 2025
₹26.55 Lakh margin 6.5%
Financial Statement Summary of Clementis Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹26.55 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | -₹32.15 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Clementis Formulation Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 6.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | -7.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Clementis Formulation are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Clementis Formulation Private Limited
Clementis Formulation has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Jigneshkumar Shah | Director | 18 Feb 2021 | 5 Years 8 Months | Current |
| Bharat Kishorchandra Shah | Director | 18 Feb 2021 | 5 Years 8 Months | Current |
Peer Comparison of Clementis Formulation Private Limited
Clementis Formulation Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Contract Research, Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Cellgen Biopharma Private Limited | ₹4.12 Cr (FY 2025) | •••• | •••• | 31.0% | •••• | New Delhi, Delhi, India |
| Elegant Drugs Private Limited | ₹4.12 Cr (FY 2025) | •••• | •••• | 89.0% | •••• | Hubli, Karnataka, India |
| Lexicare Pharma Private Limited | ₹4.11 Cr (FY 2025) | •••• | •••• | -5.0% | •••• | Ankleshwar, Gujarat, India |
| MSR Pharmaceuticals Private Limited | ₹4.11 Cr (FY 2025) | •••• | •••• | -10.0% | •••• | Patna, Bihar, India |
| Hiilsen Life Sciences Private Limited | ₹4.11 Cr (FY 2024) | •••• | •••• | 20.0% | •••• | Madurai, Tamil Nadu, India |
| Clementis Formulation Private Limited this company | ₹4.1 Cr (FY 2025) | •••• | •••• | 3831802.0% | •••• | Ahmedabad, Gujarat, India |
| Om Sai Suppliers Private Limited | ₹4.1 Cr (FY 2022) | •••• | •••• | •••• | Mumbai, Maharashtra, India | |
| Sycon Clinical Research Private Limited | ₹4.1 Cr (FY 2025) | •••• | •••• | 2.0% | •••• | Gandhinagar, Gujarat, India |
| S.V. Organics Private Limited | ₹4.1 Cr (FY 2025) | •••• | •••• | -32.0% | •••• | Hyderabad, Telangana, India |
| Brightmedex Private Limited | ₹4.09 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Chiltern International Private Limited | ₹4.09 Cr (FY 2017) | •••• | •••• | -58.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Clementis Formulation by revenue in the Pharma industry (Contract Research, Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Charges & Borrowings of Clementis Formulation Private Limited
Open charges
₹9 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 17 Jul 2023 | Others | ₹3.5 Cr | Open |
| 28 Jun 2023 | Others | ₹5.5 Cr | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Clementis Formulation Private Limited
Employment history and EPFO contributions of people linked to Clementis Formulation.
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Clementis Formulation Private Limited
Clementis Formulation Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Bharat Kishorchandra Shah was appointed as Director on 18 Feb 2021.
AGM
Clementis Formulation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Clementis Formulation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 350.00 Lakh with Charge ID 100749788 was registered on 17 Jul 2023.
Charges
A charge with Others amounted to Rs. 550.00 Lakh with Charge ID 100749789 was registered on 28 Jun 2023.
Appointed
Bharat Kishorchandra Shah was appointed as Director.
Appointed
Jigneshkumar Shah was appointed as Director.
Incorporation
18 Feb 2021
Clementis Formulation Private Limited was registered on 18 Feb 2021 with Roc Ahmedabad & aged 5 years 8 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Clementis Formulation Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Clementis Formulation Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Clementis Formulation Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Clementis Formulation Private Limited
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Clementis Formulation Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Clementis Formulation Private Limited
Clementis Formulation is an active private limited company based in Ahmedabad, Gujarat, India. The company works in industrial chemicals, within the chemicals and materials industry. It was incorporated on 18 February 2021 (5+ years old) and is registered under CIN U24290GJ2021PTC120378.
Clementis Formulation reported revenue of ₹4.1 Cr for FY 2025 (up 3831802% YoY).
Clementis Formulation has 2 current directors:
- Jigneshkumar Shah - Director
- Bharat Kishorchandra Shah - Director
Clementis Formulation reported a net loss of ₹32.15 Lakh (net margin -7.8%) and EBITDA of ₹26.55 Lakh (EBITDA margin 6.5%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Clementis Formulation is U24290GJ2021PTC120378. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Clementis Formulation was incorporated on 18 February 2021, making it 5+ years old. It is registered with the Registrar of Companies, Ahmedabad.
The peers of Clementis Formulation by revenue are Cellgen Biopharma Private Limited, Elegant Drugs Private Limited, Lexicare Pharma Private Limited, MSR Pharmaceuticals Private Limited, Hiilsen Life Sciences Private Limited and 5 more, all in the Pharma industry (Contract Research, Formulations).
Bharat Kishorchandra Shah was appointed as Director on 18 Feb 2021. Jigneshkumar Shah was appointed as Director on 18 Feb 2021.
Yes, Clementis Formulation is registered as a micro enterprise under Udyam registration (number: UDYAM-GJ-01-0225063).
The registered office of Clementis Formulation is at 279 Panchratna Estate Ar – Changodar Ta – Sanand, Ahmedabad, Gujarat, India – 382213.
Clementis Formulation has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh.